Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
207.94
+1.66 (0.80%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Biogen Revenue

Biogen had revenue of $2.74B in the quarter ending June 30, 2026, with 3.42% growth. This brings the company's revenue in the last twelve months to $10.03B, up 0.31% year-over-year. In the year 2025, Biogen had annual revenue of $9.89B with 2.22% growth.

Revenue (ttm)
$10.03B
Revenue Growth
+0.31%
P/S Ratio
3.06
Revenue / Employee
$1,337,053
Employees
7,500
Market Cap
30.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.89B214.70M2.22%
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 201914.38B925.00M6.88%
Dec 31, 201813.45B1.18B9.61%
Dec 31, 201712.27B825.10M7.21%
Dec 31, 201611.45B685.00M6.36%
Dec 31, 201510.76B1.06B10.93%
Dec 31, 20149.70B2.77B39.97%
Dec 31, 20136.93B1.42B25.66%
Dec 31, 20125.52B467.83M9.27%
Dec 31, 20115.05B332.21M7.04%
Dec 31, 20104.72B339.08M7.75%
Dec 31, 20094.38B279.84M6.83%
Dec 31, 20084.10B925.89M29.19%
Dec 31, 20073.17B488.57M18.21%
Dec 31, 20062.68B260.55M10.76%
Dec 31, 20052.42B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
GSK plc44.05B
Amgen38.10B
Revenue Rankings